Closing in on complete control over peritoneal dissemination of cancer.
A: Researchers investigated the cellular senescence and secretion of senescence-related proteins in the ascites of gastric cancer patients and found that CAFs secrete more senescence-related proteins and promote cancer progression…
Through an analysis of cellular components (cell fractions) from malignant ascites (fluid buildup in the abdomen caused by gastric cancer), a research collaboration based in Kumamoto University (Japan) has demonstrated that cellular senescence of cancer-associated fibroblasts (CAFs) play an important role in the peritoneal dissemination of gastric cancer foci (cells different from surrounding cells). This understanding should enable the development of new treatments for cancer dissemination in the peritoneum by targeting cancer cells at focal sites and CAFs in patients with gastric cancer.
Peritoneal dissemination is one type of cancer metastasis in which cancer cells break through the walls of internal organs, scatter throughout the abdomen, and grow into the peritoneum. Highly malignant gastric cancers, such as scirrhous gastric cancer, are prone to peritoneal dissemination which make them very difficult to treat. Furthermore, the development of disseminated foci is known to be closely related to the prognosis. Thus, controlling peritoneal dissemination is an important issue for improved gastric cancer treatment.
CAFs are fibroblasts that make up the cancer microenvironment, the fluids and tissues surrounding cancer cells, and are known to secrete a variety of factors involved in malignant transformations. In this study, researchers used CAFs derived from post-operative specimens of scirrhous gastric cancer patients to mimic the inflammatory environment and found that CAFs cause cellular senescence due to the release of inflammatory substances (cytokines) from cancer and surrounding cells.
Senescent cells continue to secrete senescence-associated proteins that aid in cancer cell progression and are known to cause chronic inflammation. Thus, researchers focused on changes in the epigenome of CAFs as a mechanism for the chronic secretion of these proteins. A detailed genetic analysis revealed that CAFs that underwent cellular senescence showed characteristic changes in histone modifications resulting in the activation of genes that form cellular senescence-related substances. Senescent CAFs were found to continuously secrete senescence-related proteins that promote cancer progression. Furthermore, analysis of various cell fractions from malignant ascites from patients with scirrhous gastric cancer also revealed the presence of aging CAFs.
“Our study has revealed the significance of CAFs in ascites due to peritoneal dissemination of gastric cancer,” said study leader, Dr. Takatsugu Ishimoto. “Based on our findings, a new therapeutic strategy for gastric cancer that targets cancer cells at peritoneal dissemination sites and senescent CAFs could be possible for preventing peritoneal dissemination.”
This research was posted in Cell Reports on 23 February 2021.
Yasuda, T., Koiwa, M., Yonemura, A., Miyake, K., Kariya, R., Kubota, S., … Ishimoto, T. (2021). Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination.
Cell Reports, 34(8), 108779.
J. Sanderson & N. Fukuda
Related Journal Article